Screener
Theravance Biopharma TBPH Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Theravance Biopharma’s reported figures.
Based on trailing twelve months.
The source filing: Theravance Biopharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 9:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056760
FAQ
- What is Theravance Biopharma's asset turnover?
- Theravance Biopharma (TBPH) reported asset turnover of 0.3× in Q1 2026.
- How has Theravance Biopharma's asset turnover changed year-over-year?
- Theravance Biopharma's asset turnover increased by 47.4% year-over-year, from 0.2× to 0.3×.
- What is the long-term trend for Theravance Biopharma's asset turnover?
- Over 5 years (2020 to 2025), Theravance Biopharma's asset turnover has grown at a 9.3% compound annual growth rate (CAGR), from 0.2× to 0.3×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Theravance Biopharma's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude